电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant LIV-1 (Ladiratuzumab Biosimilar) 抗体

适用: 人 ELISA, BLI, FACS, Func, SPR 宿主: Human Monoclonal unconjugated Recombinant Antibody
产品编号 ABIN7581553
发货至: 中国
  • 抗原 See all LIV-1 (Ladiratuzumab Biosimilar) products
    LIV-1 (Ladiratuzumab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    宿主
    • 1
    Human
    Expression System
    CHO Cells
    克隆类型
    • 1
    单克隆
    标记
    • 1
    This LIV-1 (Ladiratuzumab Biosimilar) antibody is un-conjugated
    应用范围
    ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
    原理
    Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumab)
    序列
    QVQLVQSGAE VKKPGASVKV SCKASGLTIE DYYMHWVRQA PGQGLEWMGW IDPENGDTEY GPKFQGRVTM TRDTSINTAY MELSRLRSDD TAVYYCAVHN AHYGTWFAYW GQGTLVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG,DVVMTQSPLS LPVTLGQPAS ISCRSSQSLL HSSGNTYLEW YQQRPGQSPR PLIYKISTRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQGSHVP YTFGGGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
    产品特性
    Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
    纯度
    >95 %
    亚型
    IgG1
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    说明

    Therapeutic Agents by Target and Mechanism: LIV-1 inhibitors

    限制
    仅限研究用
  • 状态
    Lyophilized
    浓度
    1 mg/mL
    缓冲液
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    储存条件
    4 °C,-80 °C
    储存方法
    +4°C,-80°C
  • 抗原
    LIV-1 (Ladiratuzumab Biosimilar)
    Abstract
    LIV-1 (Ladiratuzumab Biosimilar) 产品
    物质类
    Biosimilar
    分子量
    145.5 kDa
    UniProt
    Q13433
You are here:
客服